Free Express Shipping on Orders $450+ | Peptide of the Week: MT1 and MT2 - 10% Off This Week
Free Express Shipping on Orders $450+ | Peptide of the Week: MT1 and MT2 - 10% Off This Week
Melanotan I, often abbreviated as MT1, is discussed in laboratory research as a synthetic alpha-MSH analogue associated with melanocortin receptor signaling, MC1R pathway biology, pigmentation models and photobiology research.
Melanotan I is a synthetic analogue of alpha-melanocyte-stimulating hormone, commonly shortened to alpha-MSH. In research settings, it is usually associated with the peptide name [Nle4,D-Phe7]-alpha-MSH and is closely related to the clinically known compound afamelanotide.
Within the Luxara Labs research library, Melanotan I is best understood as a melanocortin receptor research peptide. Its main scientific relevance is tied to alpha-MSH pathway biology, MC1R signaling, melanin-associated cellular models and controlled photobiology research frameworks.
Melanotan I is a modified version of alpha-MSH, a peptide hormone involved in melanocortin receptor signaling. Researchers study this pathway to better understand receptor activation, melanocyte biology, pigment-related signaling and how alpha-MSH analogues interact with MC1R-linked systems.
Luxara Labs lists Melanotan I (MT1) as a research-use-only product for qualified laboratory research contexts. Researchers should evaluate identity, purity, lot details, COA documentation and storage requirements before working with any peptide material.
Melanotan I is generally associated with the alpha-MSH analogue [Nle4,D-Phe7]-alpha-MSH. This naming reflects two important substitutions compared with native alpha-MSH: norleucine at position 4 and D-phenylalanine at position 7. These substitutions are central to how the peptide is discussed in melanocortin receptor research.
| Research identity point | Melanotan I context | Why it matters for researchers |
|---|---|---|
| Common names | Melanotan I, MT1, [Nle4,D-Phe7]-alpha-MSH, afamelanotide-related peptide | These names may appear across supplier catalogs, literature and receptor biology discussions. |
| Research class | Synthetic alpha-MSH analogue and melanocortin receptor research peptide | Places MT1 within melanocortin signaling rather than general peptide marketing language. |
| Primary pathway emphasis | MC1R-associated pigmentation and melanocyte biology models | Helps distinguish MT1 from broader melanocortin compounds. |
| Clinical naming context | Afamelanotide is the regulated drug context associated with [Nle4,D-Phe7]-alpha-MSH | Clinical approval or labeling does not transfer to research-use-only materials. |
| Luxara Labs framing | Research-use-only compound for laboratory research | Not for human use, tanning use, cosmetic use, therapeutic use or self-administration. |
For broader peptide terminology, see the Luxara Labs Peptides 101 guide and the Luxara Labs Research Index.
Melanotan I research begins with alpha-MSH biology. Alpha-MSH is an endogenous melanocortin peptide that interacts with melanocortin receptors, including MC1R. In melanocyte models, MC1R activation is commonly associated with cAMP pathway signaling, melanogenesis regulation and pigmentation-related cellular responses.
Melanotan I is relevant because it is a modified alpha-MSH analogue. The Nle4 and D-Phe7 modifications have been studied for their effect on potency, stability and melanocortin receptor activity compared with native alpha-MSH.
Alpha-MSH provides the biological template for Melanotan I. Research into MT1 typically asks how modified alpha-MSH analogues interact with melanocortin receptor systems and downstream signaling.
MC1R is a major receptor in pigmentation biology. In laboratory models, MC1R signaling helps researchers study melanocyte activity, cAMP-linked pathways, melanin-associated processes and response differences across receptor variants.
MT1 and afamelanotide-related literature are often discussed in the context of photobiology and light-exposure research. This page does not make sun protection, treatment or cosmetic claims for Luxara Labs research-use material.
Melanocortin peptides can differ in how they interact with MC1R, MC3R, MC4R and MC5R. This is one reason researchers distinguish MT1 from Melanotan II and PT-141.
Melanotan I is best described as an alpha-MSH analogue studied for melanocortin receptor signaling, with particular relevance to MC1R-focused pigmentation biology, melanocyte models and photobiology research. Its value in research comes from pathway specificity, structural relationship to alpha-MSH and its contrast with broader melanocortin peptides.
Melanotan I and Melanotan II are often confused because both are melanocortin research peptides. They should not be treated as interchangeable. MT1 is more closely associated with alpha-MSH and MC1R-centered pigmentation biology, while MT2 is commonly discussed across broader melanocortin receptor research contexts.
| Comparison point | Melanotan I (MT1) | Melanotan II (MT2) |
|---|---|---|
| Research identity | Often described as [Nle4,D-Phe7]-alpha-MSH and afamelanotide-related | A distinct cyclic alpha-MSH analogue commonly discussed as MT2 |
| Main research emphasis | MC1R-focused melanocortin signaling, pigmentation biology and photobiology models | Broader melanocortin receptor activity, including MC1R, MC3R, MC4R and MC5R-related research contexts |
| Relationship to alpha-MSH | Closer full-length alpha-MSH analogue framing | Cyclic analogue with a different structural and receptor-profile discussion |
| Luxara Labs guide | This MT1 research guide | Melanotan 2 Research Guide |
| Comparison resource | Melanotan 1 vs Melanotan 2 | |
Researchers comparing MT1 and MT2 should focus on structure, receptor pathway emphasis, analytical documentation, study design and compliance language rather than consumer-facing claims.
PT-141, also known as bremelanotide in clinical context, belongs to the melanocortin research category but has a different research emphasis from MT1. Melanotan I is most often tied to alpha-MSH, MC1R and pigmentation biology, while PT-141 is frequently discussed in central melanocortin pathway models.
| Comparison point | Melanotan I (MT1) | PT-141 |
|---|---|---|
| Core category | Alpha-MSH analogue and MC1R-linked melanocortin research peptide | Melanocortin receptor research peptide with a different pathway emphasis |
| Primary research lens | Pigmentation biology, MC1R signaling, melanocyte models and photobiology | Central melanocortin signaling and behavior-pathway models |
| Research comparison | Useful when evaluating melanocortin receptor selectivity and alpha-MSH analogue design | Useful when evaluating MC receptor signaling outside a primarily pigmentation-focused framework |
| Luxara Labs resources | Melanotan I product page | PT-141 Research Guide and PT-141 vs Melanotan 2 |
Neither comparison should be used to infer human-use directions, expected effects, dosing decisions or therapeutic outcomes.
Melanotan I research is most useful when framed around specific biological systems and receptor questions. The compound should be evaluated through controlled laboratory design, analytical verification and careful interpretation of the literature.
MT1 is strongly relevant to MC1R-focused studies because alpha-MSH and MC1R are closely tied to melanocyte signaling and pigment-related cellular pathways.
Researchers may study how melanocortin pathway activation relates to melanogenesis, eumelanin-associated signaling and melanocyte response systems.
Afamelanotide-related literature provides clinical and regulatory context for photobiology, but Luxara Labs MT1 is discussed only as research-use material.
MT1 can be compared with MT2 and PT-141 to study how structural differences influence melanocortin receptor signaling profiles.
The Nle4 and D-Phe7 modifications make MT1 useful in discussions of peptide design, stability and analogue behavior compared with native alpha-MSH.
MT1 also fits into peptide quality research involving purity, identity confirmation, COA interpretation, lot matching and storage-sensitive peptide handling.
Melanotan I has a meaningful body of melanocortin and afamelanotide-related literature, but research-use materials must still be interpreted with caution. Clinical information about regulated afamelanotide products should not be used to make claims about non-clinical research-use MT1 material.
Afamelanotide has regulatory and clinical context in specific medical settings. That context helps researchers understand the broader scientific history of [Nle4,D-Phe7]-alpha-MSH, but it does not make a research-use peptide a drug, medicine, treatment, cosmetic product or human-use material.
For any melanocortin research peptide, quality documentation is central. Researchers should evaluate whether the supplier provides clear product identity, lot tracking, purity data, analytical method context and storage guidance.
| Quality checkpoint | What researchers should review | Luxara Labs resource |
|---|---|---|
| Purity | Look for purity percentage, method details and whether the COA is tied to the correct compound and lot. | Peptide Purity Standards Canada |
| Identity | Confirm that the material is identified as Melanotan I, MT1 or [Nle4,D-Phe7]-alpha-MSH rather than a different melanocortin peptide. | How to Read a COA |
| Transparency | Review whether lot information, lab documentation and supplier standards are clear. | Transparency Hub |
| Testing access | Check available lab results and whether documentation can be reviewed before research planning. | Lab Results |
| Storage | Use controlled storage and handling practices to protect peptide integrity before research use. | Peptide Storage, Handling and Stability |
| Supplier standards | Review the broader quality and compliance system behind the product listing. | Quality Standard |
For Canadian research-use context, researchers should also review Research Use Regulations Canada.
Melanotan I, also called MT1 or [Nle4,D-Phe7]-alpha-MSH, is a synthetic alpha-MSH analogue studied in melanocortin receptor research, especially MC1R-linked pigmentation biology, melanocyte signaling and photobiology models.
No. Melanotan I and Melanotan II are different melanocortin research peptides. MT1 is more closely associated with alpha-MSH and MC1R-focused research, while MT2 is commonly discussed across broader melanocortin receptor contexts.
MT1 is a common abbreviation for Melanotan I. In research literature and supplier contexts, it may also be described as [Nle4,D-Phe7]-alpha-MSH or an afamelanotide-related peptide.
Melanotan I is most closely associated with MC1R-focused research, but melanocortin receptor studies may also examine activity across related receptor systems depending on the assay and research design.
Yes. Melanotan I is a synthetic alpha-MSH analogue. Its common research identity, [Nle4,D-Phe7]-alpha-MSH, reflects structural modifications compared with native alpha-MSH.
Melanotan I is primarily discussed in relation to alpha-MSH, MC1R signaling and pigmentation biology. PT-141 is a distinct melanocortin receptor research peptide with a different research emphasis, often involving central melanocortin pathway models.
Luxara Labs does not frame Melanotan I as a tanning product. This guide discusses MT1 strictly as a research-use-only peptide for laboratory research into melanocortin receptor signaling, MC1R biology and related pathways.
No. Luxara Labs Melanotan I is for research use only. It is not intended for human use, veterinary use, clinical use, cosmetic use, tanning use, treatment use or self-administration.
Researchers should review product identity, lot number, purity percentage, testing method, documentation clarity and whether the COA matches the exact compound being evaluated. The Luxara Labs guide on how to read a COA explains these points in more detail.
Yes. Luxara Labs lists Melanotan I (MT1) as a research-use-only product at https://luxaralabs.com/product/melanotan-1-mt1/.
Melanotan I (MT1) products from Luxara Labs are sold for research use only. They are not intended for human consumption, veterinary use, clinical use, diagnostic use, cosmetic use, tanning use, therapeutic use, performance use or self-administration. This page is educational and research-focused. It does not provide medical advice, dosing instructions, treatment recommendations or consumer-use guidance.
Join our list and get an instant 10% discount code — valid for first-time buyers.
